Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Sep 13;22(1):339.
doi: 10.1186/s12893-022-01789-4.

Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis

Liangliang Xu  1 , Fuzhen Dai  2 , Peng Wang  1 , Lian Li  1 , Ming Zhang  1 , Mingqing Xu  3
Affiliations
Randomized Controlled Trial

Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis

Liangliang Xu et al. BMC Surg. .

Abstract

Background: Liver cirrhosis is a well-known risk factor for carcinogenesis of hepatocellular carcinoma (HCC). The aim of the present study was to construct individual prognostic models for HCC with cirrhosis.

Methods: The clinical differences between HCC patients with and without cirrhosis were compared using a large cohort of 1003 cases. The patients with cirrhosis were randomly divided into a training cohort and a validation cohort in a ratio of 2:1. Univariate and multivariate analyses were performed to reveal the independent risk factors for recurrence-free survival (RFS) and overall survival (OS) in HCC patients with cirrhosis. These factors were subsequently used to construct nomograms.

Results: Multivariate analyses revealed that five clinical variables (hepatitis B e antigen (HBeAg) positivity, alpha-fetoprotein (AFP) level, tumour diameter, microvascular invasion (MVI), and satellite lesions) and seven variables (HBeAg positivity, AFP level, tumour diameter, MVI, satellite lesions, gamma-glutamyl transpeptidase level, and histological differentiation) were significantly associated with RFS and OS, respectively. The C-indices of the nomograms for RFS and OS were 0.739 (P < 0.001) and 0.789 (P < 0.001), respectively, in the training cohort, and 0.752 (P < 0.001) and 0.813 (P < 0.001), respectively, in the validation cohort. The C-indices of the nomograms were significantly higher than those of conventional staging systems (P < 0.001). The calibration plots showed optimal consistence between the nomogram-predicted and observed prognoses.

Conclusions: The nomograms developed in the present study showed good performance in predicting the prognoses of HCC patients with hepatitis B virus-associated cirrhosis.

Keywords: Cirrhosis; Hepatitis B virus; Hepatocellular carcinoma; Nomogram; Prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The fibrosis extent of included patients with HCC was evaluated by Ishak scoring system
Fig. 2
Fig. 2
Nomograms for predicting recurrence-free survival (RFS) (a) and overall survival (OS) (b) in cirrhotic patients with HCC who underwent curative liver resection. HBeAg hepatitis B e antigen, AFP alpha-fetoprotein, MVI microvascular invasion, GGT gamma-glutamyl transpeptidase
Fig. 3
Fig. 3
Calibration curves for predicting Recurrence-free survival (RFS) and overall survival (OS) using the nomograms. a and b 3 and 5-year RFS in the training cohort. c and d 3 and 5-year OS in the training cohort. e and f 3 and 5-year RFS in the validation cohort. g and h 3 and 5-year OS in the validation cohort
See this image and copyright information in PMC

References

    1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi: 10.3322/caac.21262. - DOI - PubMed
    1. Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018. doi: 10.1038/nrdp.2016.18. - DOI - PubMed
    1. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264–73.e1. doi: 10.1053/j.gastro.2011.12.061. - DOI - PMC - PubMed
    1. Liu J, Fan D. Hepatitis B in China. Lancet. 2007;369(9573):1582–1583. doi: 10.1016/s0140-6736(07)60723-5. - DOI - PubMed
    1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi: 10.3322/caac.21338. - DOI - PubMed

Publication types